Pharmaceutical products comprising bisphosphonates

Details for Australian Patent Application No. 2004271731 (hide)

Owner Novartis AG Novartis Pharma GmbH

Inventors Sigg, Juergen; Glausch, Alexandra; Loffler, Rolf

Agent Davies Collison Cave

Pub. Number AU-B-2004271731

PCT Pub. Number WO2005/025551

Priority 60/504,402 18.09.03 US

Filing date 17 September 2004

Wipo publication date 24 March 2005

Acceptance publication date 24 July 2008

International Classifications

A61K 31/66 (2006.01) - Phosphorus compounds

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/00 (2006.01)

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/025551 Priority application(s): WO2005/025551

24 July 2008 Application Accepted

  Published as AU-B-2004271731

20 November 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004271740-Benzothiazole derivatives for the treatment of diabetes

2004271730-Combination of a histone deacetylase inhibitor with a death receptor ligand